US Patent Issued to Gentian AS on March 17 for "Methods for determining the concentration of an analyte in the plasma fraction of a sample of whole blood" (Norwegian, Swedish Inventors)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,578,330, issued on March 17, was assigned to Gentian AS (Moss, Norway).

"Methods for determining the concentration of an analyte in the plasma fraction of a sample of whole blood" was invented by Erling Sundrehagen (Moss, Norway), Kathrin Sunde (Moss, Norway), Camilla Fant (Kullavik, Sweden), Olov Wahlsten (Gothenburg, Sweden) and Clara Mathilde Hidden (Vestby, Norway).

According to the abstract* released by the U.S. Patent & Trademark Office: "The precision of a lateral flow assay for determining the concentration of an analyte in the plasma fraction of a sample of whole blood can be significantly improved by applying an integrated step for determining the hematocrit of the optiona...